Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Friis

Showing results (91-100 of 154) with videos related to

Pageof 16
Sort By:
British Journal of Cancer|April 7, 2005
A cohort study of antihypertensive treatments and risk of renal cell cancerJ P Fryzek, A H Poulsen, S P Johnsen, et al.
British Journal of Cancer|December 22, 2004
Use of antibiotics and risk of breast cancer: a population-based case-control studyH T Sørensen, M V Skriver, S Friis, et al.
Annals of Plastic Surgery|July 1, 1997
Connective tissue disease and other rheumatic conditions following breast implants in DenmarkS Friis, L Mellemkjaer, J K McLaughlin, et al.
European Journal of Neurology|February 28, 2014
Myasthenia and risk of cancer: a population-based case-control studyE G Pedersen, A Pottegård, J Hallas, et al.
European Journal of Neurology|December 17, 2013
Risk of non-melanoma skin cancer in myasthenia patients treated with azathioprineE G Pedersen, A Pottegård, J Hallas, et al.
Journal of Internal Medicine|May 9, 2017
Hydrochlorothiazide use is strongly associated with risk of lip cancerA Pottegård, J Hallas, M Olesen, et al.
European Journal of Neurology|March 2, 2013
Use of azathioprine for non-thymoma myasthenia and risk of cancer: a nationwide case-control study in DenmarkE G Pedersen, A Pottegård, J Hallas, et al.
Oncotarget|April 1, 2015
Hypomethylation and up-regulation of PD-1 in T cells by azacytidine in MDS/AML patients: A rationale for combined targeting of PD-1 and DNA methylationAndreas D Ørskov, Marianne B Treppendahl, Anni Skovbo, et al.
Alimentary Pharmacology & Therapeutics|March 27, 2004
COX-2-selective inhibitors and the risk of upper gastrointestinal bleeding in high-risk patients with previous gastrointestinal diseases: a population-based case-control studyB Nørgård, L Pedersen, S P Johnsen, et al.
European Journal of Haematology|September 25, 2022
Pulmonary function is a strong predictor of 2-year overall survival and non-relapse mortality after allogenic hematopoietic cell transplantationFrederikke Schierbeck, Jann Mortensen, Niels S Andersen, et al.
Pageof 16

Showing results (91-100 of 154) with videos related to

Sort By:
Pageof 16
British Journal of Cancer|April 7, 2005
A cohort study of antihypertensive treatments and risk of renal cell cancerJ P Fryzek, A H Poulsen, S P Johnsen, et al.
British Journal of Cancer|December 22, 2004
Use of antibiotics and risk of breast cancer: a population-based case-control studyH T Sørensen, M V Skriver, S Friis, et al.
Annals of Plastic Surgery|July 1, 1997
Connective tissue disease and other rheumatic conditions following breast implants in DenmarkS Friis, L Mellemkjaer, J K McLaughlin, et al.
European Journal of Neurology|February 28, 2014
Myasthenia and risk of cancer: a population-based case-control studyE G Pedersen, A Pottegård, J Hallas, et al.
European Journal of Neurology|December 17, 2013
Risk of non-melanoma skin cancer in myasthenia patients treated with azathioprineE G Pedersen, A Pottegård, J Hallas, et al.
Journal of Internal Medicine|May 9, 2017
Hydrochlorothiazide use is strongly associated with risk of lip cancerA Pottegård, J Hallas, M Olesen, et al.
European Journal of Neurology|March 2, 2013
Use of azathioprine for non-thymoma myasthenia and risk of cancer: a nationwide case-control study in DenmarkE G Pedersen, A Pottegård, J Hallas, et al.
Oncotarget|April 1, 2015
Hypomethylation and up-regulation of PD-1 in T cells by azacytidine in MDS/AML patients: A rationale for combined targeting of PD-1 and DNA methylationAndreas D Ørskov, Marianne B Treppendahl, Anni Skovbo, et al.
Alimentary Pharmacology & Therapeutics|March 27, 2004
COX-2-selective inhibitors and the risk of upper gastrointestinal bleeding in high-risk patients with previous gastrointestinal diseases: a population-based case-control studyB Nørgård, L Pedersen, S P Johnsen, et al.
European Journal of Haematology|September 25, 2022
Pulmonary function is a strong predictor of 2-year overall survival and non-relapse mortality after allogenic hematopoietic cell transplantationFrederikke Schierbeck, Jann Mortensen, Niels S Andersen, et al.
Pageof 16